Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: NZ$0.44 M
• Last 3 months FTD volume: NZ$3.3 M
• Last 12 months FTD volume: NZ$9.95 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Ultragenyx Pharmaceutical RARE	NZ$1.71 M	NZ$7.18 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	NZ$2.8 M	NZ$17.38 M	🇺🇸 USA
Pfizer PFE	NZ$24.63 M	NZ$0.10 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	NZ$5.36 M	NZ$70.47 M	🇺🇸 USA
Amicus Therapeutics FOLD	NZ$7.34 M	NZ$13.62 M	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	NZ$0.58 M	NZ$12.15 M	🇺🇸 USA